Trevena Stock Skyrockets: Pain Treatment’s Chinese Approval Results in 5x Gain and Frenzied Trading!
Shares of Trevena Inc. (TRVN) soared more than five-fold higher, up 420.6% on active trading Monday after the biopharmaceutical company announced that its China-based partner Jiangsu Nhwa received formal approval from Chinese health regulators for the pain treatment Olinvyk. The Pennsylvania-based firm saw 75.7 million shares change hands, compared with the full-day average over the […]